imbiologics

ybiologics

The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.

immunos

This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Bioinvent International

This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

SELECXINE

Selecxine develops antibody-cytokine conjugates for cancer treatment, providing these immunotherapeutic biologics to the pharmaceutical industry and clinical research institutions.

Timberlyne

This biopharmaceutical company develops monoclonal antibody therapies for patients with autoimmune disorders and cancers.